Re-treatment with cetuximab in patients with severe hypersensitivity reactions to cetuximab. Two case reports

被引:11
作者
Nielsen, Dorte L. [1 ]
Pfeiffer, Per
Vittrup Jensen, Benny
机构
[1] Univ Copenhagen, Herlev Hosp, Dept Oncol, DK-2730 Herlev, Denmark
[2] Odense Univ Hosp, Dept Oncol, Odense, Denmark
关键词
D O I
10.1080/02841860600871764
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1137 / 1138
页数:2
相关论文
共 2 条
[1]   Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer [J].
Cunningham, D ;
Humblet, Y ;
Siena, S ;
Khayat, D ;
Bleiberg, H ;
Santoro, A ;
Bets, D ;
Mueser, M ;
Harstrick, A ;
Verslype, C ;
Chau, I ;
Van Cutsem, E .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (04) :337-345
[2]   Cetuximab: An epidermal growth factor receptor monoclonal antibody for the treatment of colorectal cancer [J].
Wong, SF .
CLINICAL THERAPEUTICS, 2005, 27 (06) :684-694